Global Prescription Arthritis Medications Market Research Report 2023

Arthritis medicines are generally very effective in helping people with arthritis to manage joint pain and other symptoms.

The global Prescription Arthritis Medications market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Prescription Arthritis Medications is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Prescription Arthritis Medications is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Prescription Arthritis Medications include Abbott, Amgen, Boehringer Ingelheim, Horizon Pharma, Novartis, Pfizer and Regeneron, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Prescription Arthritis Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Arthritis Medications.

The Prescription Arthritis Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prescription Arthritis Medications market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prescription Arthritis Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Prescription Arthritis Medications

1.2 Prescription Arthritis Medications Segment by Type

1.2.1 Global Prescription Arthritis Medications Market Value Comparison by Type (2023-2029)

1.2.2 Oral

1.2.3 Topical

1.3 Prescription Arthritis Medications Segment by Application

1.3.1 Global Prescription Arthritis Medications Market Value by Application: (2023-2029)

1.3.2 Hospital Pharmacies

1.3.3 Online Pharmacies

1.3.4 Retail Pharmacies

1.4 Global Prescription Arthritis Medications Market Size Estimates and Forecasts

1.4.1 Global Prescription Arthritis Medications Revenue 2018-2029

1.4.2 Global Prescription Arthritis Medications Sales 2018-2029

1.4.3 Global Prescription Arthritis Medications Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Prescription Arthritis Medications Sales Market Share by Manufacturers (2018-2023)

2.2 Global Prescription Arthritis Medications Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Prescription Arthritis Medications Average Price by Manufacturers (2018-2023)

2.4 Global Prescription Arthritis Medications Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Prescription Arthritis Medications, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Prescription Arthritis Medications, Product Type & Application

2.7 Prescription Arthritis Medications Market Competitive Situation and Trends

2.7.1 Prescription Arthritis Medications Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Prescription Arthritis Medications Players Market Share by Revenue

2.7.3 Global Prescription Arthritis Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Prescription Arthritis Medications Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Prescription Arthritis Medications Global Prescription Arthritis Medications Sales by Region: 2018-2029

3.2.1 Global Prescription Arthritis Medications Sales by Region: 2018-2023

3.2.2 Global Prescription Arthritis Medications Sales by Region: 2024-2029

3.3 Global Prescription Arthritis Medications Global Prescription Arthritis Medications Revenue by Region: 2018-2029

3.3.1 Global Prescription Arthritis Medications Revenue by Region: 2018-2023

3.3.2 Global Prescription Arthritis Medications Revenue by Region: 2024-2029

3.4 North America Prescription Arthritis Medications Market Facts & Figures by Country

3.4.1 North America Prescription Arthritis Medications Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Prescription Arthritis Medications Sales by Country (2018-2029)

3.4.3 North America Prescription Arthritis Medications Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Prescription Arthritis Medications Market Facts & Figures by Country

3.5.1 Europe Prescription Arthritis Medications Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Prescription Arthritis Medications Sales by Country (2018-2029)

3.5.3 Europe Prescription Arthritis Medications Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Prescription Arthritis Medications Market Facts & Figures by Country

3.6.1 Asia Pacific Prescription Arthritis Medications Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Prescription Arthritis Medications Sales by Country (2018-2029)

3.6.3 Asia Pacific Prescription Arthritis Medications Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Prescription Arthritis Medications Market Facts & Figures by Country

3.7.1 Latin America Prescription Arthritis Medications Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Prescription Arthritis Medications Sales by Country (2018-2029)

3.7.3 Latin America Prescription Arthritis Medications Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Prescription Arthritis Medications Market Facts & Figures by Country

3.8.1 Middle East and Africa Prescription Arthritis Medications Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Prescription Arthritis Medications Sales by Country (2018-2029)

3.8.3 Middle East and Africa Prescription Arthritis Medications Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Prescription Arthritis Medications Sales by Type (2018-2029)

4.1.1 Global Prescription Arthritis Medications Sales by Type (2018-2023)

4.1.2 Global Prescription Arthritis Medications Sales by Type (2024-2029)

4.1.3 Global Prescription Arthritis Medications Sales Market Share by Type (2018-2029)

4.2 Global Prescription Arthritis Medications Revenue by Type (2018-2029)

4.2.1 Global Prescription Arthritis Medications Revenue by Type (2018-2023)

4.2.2 Global Prescription Arthritis Medications Revenue by Type (2024-2029)

4.2.3 Global Prescription Arthritis Medications Revenue Market Share by Type (2018-2029)

4.3 Global Prescription Arthritis Medications Price by Type (2018-2029)

5.1 Global Prescription Arthritis Medications Sales by Application (2018-2029)

5.1.1 Global Prescription Arthritis Medications Sales by Application (2018-2023)

5.1.2 Global Prescription Arthritis Medications Sales by Application (2024-2029)

5.1.3 Global Prescription Arthritis Medications Sales Market Share by Application (2018-2029)

5.2 Global Prescription Arthritis Medications Revenue by Application (2018-2029)

5.2.1 Global Prescription Arthritis Medications Revenue by Application (2018-2023)

5.2.2 Global Prescription Arthritis Medications Revenue by Application (2024-2029)

5.2.3 Global Prescription Arthritis Medications Revenue Market Share by Application (2018-2029)

5.3 Global Prescription Arthritis Medications Price by Application (2018-2029)

6.1 Abbott

6.1.1 Abbott Corporation Information

6.1.2 Abbott Description and Business Overview

6.1.3 Abbott Prescription Arthritis Medications Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Abbott Prescription Arthritis Medications Product Portfolio

6.1.5 Abbott Recent Developments/Updates

6.2 Amgen

6.2.1 Amgen Corporation Information

6.2.2 Amgen Description and Business Overview

6.2.3 Amgen Prescription Arthritis Medications Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Amgen Prescription Arthritis Medications Product Portfolio

6.2.5 Amgen Recent Developments/Updates

6.3 Boehringer Ingelheim

6.3.1 Boehringer Ingelheim Corporation Information

6.3.2 Boehringer Ingelheim Description and Business Overview

6.3.3 Boehringer Ingelheim Prescription Arthritis Medications Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Boehringer Ingelheim Prescription Arthritis Medications Product Portfolio

6.3.5 Boehringer Ingelheim Recent Developments/Updates

6.4 Horizon Pharma

6.4.1 Horizon Pharma Corporation Information

6.4.2 Horizon Pharma Description and Business Overview

6.4.3 Horizon Pharma Prescription Arthritis Medications Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Horizon Pharma Prescription Arthritis Medications Product Portfolio

6.4.5 Horizon Pharma Recent Developments/Updates

6.5 Novartis

6.5.1 Novartis Corporation Information

6.5.2 Novartis Description and Business Overview

6.5.3 Novartis Prescription Arthritis Medications Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Novartis Prescription Arthritis Medications Product Portfolio

6.5.5 Novartis Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Prescription Arthritis Medications Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Pfizer Prescription Arthritis Medications Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

6.7 Regeneron

6.6.1 Regeneron Corporation Information

6.6.2 Regeneron Description and Business Overview

6.6.3 Regeneron Prescription Arthritis Medications Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Regeneron Prescription Arthritis Medications Product Portfolio

6.7.5 Regeneron Recent Developments/Updates

7.1 Prescription Arthritis Medications Industry Chain Analysis

7.2 Prescription Arthritis Medications Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Prescription Arthritis Medications Production Mode & Process

7.4 Prescription Arthritis Medications Sales and Marketing

7.4.1 Prescription Arthritis Medications Sales Channels

7.4.2 Prescription Arthritis Medications Distributors

7.5 Prescription Arthritis Medications Customers

8.1 Prescription Arthritis Medications Industry Trends

8.2 Prescription Arthritis Medications Market Drivers

8.3 Prescription Arthritis Medications Market Challenges

8.4 Prescription Arthritis Medications Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Prescription Arthritis Medications Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Prescription Arthritis Medications Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Prescription Arthritis Medications Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Prescription Arthritis Medications Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Prescription Arthritis Medications Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Prescription Arthritis Medications Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Prescription Arthritis Medications Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Prescription Arthritis Medications Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Prescription Arthritis Medications, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Prescription Arthritis Medications, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Prescription Arthritis Medications, Product Type & Application

    Table 12. Global Key Manufacturers of Prescription Arthritis Medications, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Prescription Arthritis Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Arthritis Medications as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Prescription Arthritis Medications Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Prescription Arthritis Medications Sales by Region (2018-2023) & (K Units)

    Table 18. Global Prescription Arthritis Medications Sales Market Share by Region (2018-2023)

    Table 19. Global Prescription Arthritis Medications Sales by Region (2024-2029) & (K Units)

    Table 20. Global Prescription Arthritis Medications Sales Market Share by Region (2024-2029)

    Table 21. Global Prescription Arthritis Medications Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Prescription Arthritis Medications Revenue Market Share by Region (2018-2023)

    Table 23. Global Prescription Arthritis Medications Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Prescription Arthritis Medications Revenue Market Share by Region (2024-2029)

    Table 25. North America Prescription Arthritis Medications Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Prescription Arthritis Medications Sales by Country (2018-2023) & (K Units)

    Table 27. North America Prescription Arthritis Medications Sales by Country (2024-2029) & (K Units)

    Table 28. North America Prescription Arthritis Medications Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Prescription Arthritis Medications Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Prescription Arthritis Medications Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Prescription Arthritis Medications Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Prescription Arthritis Medications Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Prescription Arthritis Medications Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Prescription Arthritis Medications Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Prescription Arthritis Medications Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Prescription Arthritis Medications Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Prescription Arthritis Medications Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Prescription Arthritis Medications Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Prescription Arthritis Medications Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Prescription Arthritis Medications Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Prescription Arthritis Medications Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Prescription Arthritis Medications Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Prescription Arthritis Medications Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Prescription Arthritis Medications Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Prescription Arthritis Medications Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Prescription Arthritis Medications Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Prescription Arthritis Medications Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Prescription Arthritis Medications Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Prescription Arthritis Medications Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Prescription Arthritis Medications Sales (K Units) by Type (2018-2023)

    Table 51. Global Prescription Arthritis Medications Sales (K Units) by Type (2024-2029)

    Table 52. Global Prescription Arthritis Medications Sales Market Share by Type (2018-2023)

    Table 53. Global Prescription Arthritis Medications Sales Market Share by Type (2024-2029)

    Table 54. Global Prescription Arthritis Medications Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Prescription Arthritis Medications Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Prescription Arthritis Medications Revenue Market Share by Type (2018-2023)

    Table 57. Global Prescription Arthritis Medications Revenue Market Share by Type (2024-2029)

    Table 58. Global Prescription Arthritis Medications Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Prescription Arthritis Medications Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Prescription Arthritis Medications Sales (K Units) by Application (2018-2023)

    Table 61. Global Prescription Arthritis Medications Sales (K Units) by Application (2024-2029)

    Table 62. Global Prescription Arthritis Medications Sales Market Share by Application (2018-2023)

    Table 63. Global Prescription Arthritis Medications Sales Market Share by Application (2024-2029)

    Table 64. Global Prescription Arthritis Medications Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Prescription Arthritis Medications Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Prescription Arthritis Medications Revenue Market Share by Application (2018-2023)

    Table 67. Global Prescription Arthritis Medications Revenue Market Share by Application (2024-2029)

    Table 68. Global Prescription Arthritis Medications Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Prescription Arthritis Medications Price (USD/Unit) by Application (2024-2029)

    Table 70. Abbott Corporation Information

    Table 71. Abbott Description and Business Overview

    Table 72. Abbott Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. Abbott Prescription Arthritis Medications Product

    Table 74. Abbott Recent Developments/Updates

    Table 75. Amgen Corporation Information

    Table 76. Amgen Description and Business Overview

    Table 77. Amgen Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Amgen Prescription Arthritis Medications Product

    Table 79. Amgen Recent Developments/Updates

    Table 80. Boehringer Ingelheim Corporation Information

    Table 81. Boehringer Ingelheim Description and Business Overview

    Table 82. Boehringer Ingelheim Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Boehringer Ingelheim Prescription Arthritis Medications Product

    Table 84. Boehringer Ingelheim Recent Developments/Updates

    Table 85. Horizon Pharma Corporation Information

    Table 86. Horizon Pharma Description and Business Overview

    Table 87. Horizon Pharma Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. Horizon Pharma Prescription Arthritis Medications Product

    Table 89. Horizon Pharma Recent Developments/Updates

    Table 90. Novartis Corporation Information

    Table 91. Novartis Description and Business Overview

    Table 92. Novartis Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Novartis Prescription Arthritis Medications Product

    Table 94. Novartis Recent Developments/Updates

    Table 95. Pfizer Corporation Information

    Table 96. Pfizer Description and Business Overview

    Table 97. Pfizer Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Pfizer Prescription Arthritis Medications Product

    Table 99. Pfizer Recent Developments/Updates

    Table 100. Regeneron Corporation Information

    Table 101. Regeneron Description and Business Overview

    Table 102. Regeneron Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. Regeneron Prescription Arthritis Medications Product

    Table 104. Regeneron Recent Developments/Updates

    Table 105. Key Raw Materials Lists

    Table 106. Raw Materials Key Suppliers Lists

    Table 107. Prescription Arthritis Medications Distributors List

    Table 108. Prescription Arthritis Medications Customers List

    Table 109. Prescription Arthritis Medications Market Trends

    Table 110. Prescription Arthritis Medications Market Drivers

    Table 111. Prescription Arthritis Medications Market Challenges

    Table 112. Prescription Arthritis Medications Market Restraints

    Table 113. Research Programs/Design for This Report

    Table 114. Key Data Information from Secondary Sources

    Table 115. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Prescription Arthritis Medications

    Figure 2. Global Prescription Arthritis Medications Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Prescription Arthritis Medications Market Share by Type in 2022 & 2029

    Figure 4. Oral Product Picture

    Figure 5. Topical Product Picture

    Figure 6. Global Prescription Arthritis Medications Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Prescription Arthritis Medications Market Share by Application in 2022 & 2029

    Figure 8. Hospital Pharmacies

    Figure 9. Online Pharmacies

    Figure 10. Retail Pharmacies

    Figure 11. Global Prescription Arthritis Medications Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Prescription Arthritis Medications Market Size (2018-2029) & (US$ Million)

    Figure 13. Global Prescription Arthritis Medications Sales (2018-2029) & (K Units)

    Figure 14. Global Prescription Arthritis Medications Average Price (USD/Unit) & (2018-2029)

    Figure 15. Prescription Arthritis Medications Report Years Considered

    Figure 16. Prescription Arthritis Medications Sales Share by Manufacturers in 2022

    Figure 17. Global Prescription Arthritis Medications Revenue Share by Manufacturers in 2022

    Figure 18. The Global 5 and 10 Largest Prescription Arthritis Medications Players: Market Share by Revenue in 2022

    Figure 19. Prescription Arthritis Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 20. Global Prescription Arthritis Medications Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 21. North America Prescription Arthritis Medications Sales Market Share by Country (2018-2029)

    Figure 22. North America Prescription Arthritis Medications Revenue Market Share by Country (2018-2029)

    Figure 23. U.S. Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Canada Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Europe Prescription Arthritis Medications Sales Market Share by Country (2018-2029)

    Figure 26. Europe Prescription Arthritis Medications Revenue Market Share by Country (2018-2029)

    Figure 27. Germany Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. France Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. U.K. Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Italy Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Russia Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Asia Pacific Prescription Arthritis Medications Sales Market Share by Region (2018-2029)

    Figure 33. Asia Pacific Prescription Arthritis Medications Revenue Market Share by Region (2018-2029)

    Figure 34. China Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Japan Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. South Korea Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. India Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Australia Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Taiwan Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Indonesia Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Thailand Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Malaysia Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Philippines Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Latin America Prescription Arthritis Medications Sales Market Share by Country (2018-2029)

    Figure 45. Latin America Prescription Arthritis Medications Revenue Market Share by Country (2018-2029)

    Figure 46. Mexico Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Brazil Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Argentina Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa Prescription Arthritis Medications Sales Market Share by Country (2018-2029)

    Figure 50. Middle East & Africa Prescription Arthritis Medications Revenue Market Share by Country (2018-2029)

    Figure 51. Turkey Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Saudi Arabia Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. U.A.E Prescription Arthritis Medications Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Global Sales Market Share of Prescription Arthritis Medications by Type (2018-2029)

    Figure 55. Global Revenue Market Share of Prescription Arthritis Medications by Type (2018-2029)

    Figure 56. Global Prescription Arthritis Medications Price (USD/Unit) by Type (2018-2029)

    Figure 57. Global Sales Market Share of Prescription Arthritis Medications by Application (2018-2029)

    Figure 58. Global Revenue Market Share of Prescription Arthritis Medications by Application (2018-2029)

    Figure 59. Global Prescription Arthritis Medications Price (USD/Unit) by Application (2018-2029)

    Figure 60. Prescription Arthritis Medications Value Chain

    Figure 61. Prescription Arthritis Medications Production Process

    Figure 62. Channels of Distribution (Direct Vs Distribution)

    Figure 63. Distributors Profiles

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed